AU2006214332B2 - Replikin peptides and uses thereof - Google Patents

Replikin peptides and uses thereof Download PDF

Info

Publication number
AU2006214332B2
AU2006214332B2 AU2006214332A AU2006214332A AU2006214332B2 AU 2006214332 B2 AU2006214332 B2 AU 2006214332B2 AU 2006214332 A AU2006214332 A AU 2006214332A AU 2006214332 A AU2006214332 A AU 2006214332A AU 2006214332 B2 AU2006214332 B2 AU 2006214332B2
Authority
AU
Australia
Prior art keywords
replikin
virus
influenza
replikins
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006214332A
Other languages
English (en)
Other versions
AU2006214332A1 (en
Inventor
Elenore S. Bogoch
Samuel Bogoch
Samuel Winston Bogoch
Anne-Elenore Elizabeth Borsanyl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BORSANYI ANNE ELENORE BOGOCH
Original Assignee
BORSANYI ANNE ELENORE BOGOCH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/014443 external-priority patent/WO2005104754A2/en
Application filed by BORSANYI ANNE ELENORE BOGOCH filed Critical BORSANYI ANNE ELENORE BOGOCH
Publication of AU2006214332A1 publication Critical patent/AU2006214332A1/en
Application granted granted Critical
Publication of AU2006214332B2 publication Critical patent/AU2006214332B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AU2006214332A 2005-02-16 2006-02-16 Replikin peptides and uses thereof Ceased AU2006214332B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US65308305P 2005-02-16 2005-02-16
US60/653,083 2005-02-16
PCT/US2005/014443 WO2005104754A2 (en) 2004-04-28 2005-04-28 System and method for identifying complex patterns of amino acids
AUPCT/US2005/014443 2005-04-28
PCT/US2006/005343 WO2006088962A2 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof

Publications (2)

Publication Number Publication Date
AU2006214332A1 AU2006214332A1 (en) 2006-08-24
AU2006214332B2 true AU2006214332B2 (en) 2012-03-22

Family

ID=36917023

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006214332A Ceased AU2006214332B2 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof

Country Status (8)

Country Link
EP (1) EP1859063A4 (enExample)
JP (1) JP2008539164A (enExample)
AU (1) AU2006214332B2 (enExample)
CA (1) CA2598381A1 (enExample)
IL (1) IL185308A0 (enExample)
NZ (1) NZ560415A (enExample)
SG (1) SG160327A1 (enExample)
WO (1) WO2006088962A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CA2653702A1 (en) * 2006-05-30 2008-05-22 Samuel Bogoch Replikin peptides and uses thereof
EP2092059A4 (en) 2006-10-24 2012-03-28 Bogoch Samuel METHOD FOR FORECASTING INFLUENZA EXCESSIONS BY CORRELATION OF AN INCREASED REPLICINE MIRROR IN WHITE SPOT AND / OR TAURA VIRUSES IN CRABES
US20090017052A1 (en) 2007-01-18 2009-01-15 Samuel Bogoch Methods of determining lethality of pathogens and malignancies involving replikin peak genes
MX2009013091A (es) * 2007-05-30 2010-07-30 Bogoch Samuel Peptidos de repliquina sinteticos contra infeccion patogenica de invertebrados en acuicultura.
EP2300493A2 (en) * 2008-04-23 2011-03-30 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
EP2320932B1 (en) * 2008-08-08 2015-07-15 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
EP2421546A1 (en) * 2009-04-23 2012-02-29 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
CA2842345A1 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
US20130243803A1 (en) 2012-03-09 2013-09-19 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005010032A2 (en) * 2003-06-06 2005-02-03 Samuel Bogoch Replikin peptides and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0221748A3 (en) 1985-11-01 1988-10-12 Samuel Dr. Bogoch A process for the production of human antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6242578B1 (en) 1994-02-17 2001-06-05 Samuel Bogoch Aglyco products and methods of use
US7420028B2 (en) * 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US11620305B2 (en) 2021-03-25 2023-04-04 Salesforce.Com, Inc Ruleset engine for generating homogeneous data sets

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005010032A2 (en) * 2003-06-06 2005-02-03 Samuel Bogoch Replikin peptides and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Genbank Accession No. AAV74400 *

Also Published As

Publication number Publication date
WO2006088962A2 (en) 2006-08-24
WO2006088962A9 (en) 2006-11-16
EP1859063A4 (en) 2012-02-01
WO2006088962A3 (en) 2008-01-24
EP1859063A2 (en) 2007-11-28
SG160327A1 (en) 2010-04-29
CA2598381A1 (en) 2006-08-24
JP2008539164A (ja) 2008-11-13
IL185308A0 (en) 2008-02-09
NZ560415A (en) 2010-05-28
AU2006214332A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
US7894999B2 (en) Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
Luczo et al. Epitopes in the HA and NA of H5 and H7 avian influenza viruses that are important for antigenic drift
Anderson et al. Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain
Allen et al. Next generation methodology for updating HA vaccines against emerging human seasonal influenza A (H3N2) viruses
AU2010200602B2 (en) Replikin peptides and uses thereof
Li et al. Selection of antigenically advanced variants of seasonal influenza viruses
US7189800B2 (en) Replikin peptides in rapid replication of glioma cells and in influenza epidemics
US9388234B2 (en) Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
Goldenberg et al. Genetic and antigenic characterization of sigma C protein from avian reovirus
AU2002309514B2 (en) Replikin peptides and uses thereof
Waqas et al. Immunoinformatics and molecular docking studies predicted potential multiepitope‐based peptide vaccine and novel compounds against novel SARS‐CoV‐2 through virtual screening
EP1859063A2 (en) Replikin peptides and uses thereof
Gong et al. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B
EP2027146A2 (en) Replikin peptides and uses thereof
KR20030088476A (ko) 레플리킨 펩타이드 및 그의 이용
US9254315B2 (en) Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
NZ584367A (en) Systems and methods for indentifying Replikin scaffolds and uses of said Replikin scaffolds
Mendoza et al. Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019–2020 Season in Philadelphia, Pennsylvania
Lotfian et al. The recombinant immunodominant regions 179-344 and 550-670 from SARS-COV2 spike protein can efficiently react with patients' sera
KR101072249B1 (ko) 레플리킨 펩타이드 및 그의 이용

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired